Sales decline 16.37% to Rs 140.73 crore
Net profit of Panacea Biotec reported to Rs 1237.42 crore in the quarter ended March 2022 as against net loss of Rs 54.10 crore during the previous quarter ended March 2021. Sales declined 16.37% to Rs 140.73 crore in the quarter ended March 2022 as against Rs 168.27 crore during the previous quarter ended March 2021.For the full year,net profit reported to Rs 1077.89 crore in the year ended March 2022 as against net loss of Rs 147.69 crore during the previous year ended March 2021. Sales rose 5.83% to Rs 661.23 crore in the year ended March 2022 as against Rs 624.81 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales140.73168.27 -16 661.23624.81 6 OPM %-21.450.56 --2.1012.03 - PBDT-56.80-41.07 -38 -183.73-100.09 -84 PBT-67.95-52.65 -29 -227.39-145.69 -56 NP1237.42-54.10 LP 1077.89-147.69 LP
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
